Incyte to Present at Upcoming Investor Conference
Incyte (Nasdaq: INCY) announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference.
The event will be held on Monday, January 13, 2025, at 10:30 am (PST). The presentation will be webcast live and accessible through Investor.Incyte.com. A replay of the webcast will be available for 30 days.
Incyte (Nasdaq: INCY) ha annunciato la sua partecipazione alla 43esima Conferenza Annuale sulla Sanità J.P. Morgan.
L'evento si terrà lunedì 13 gennaio 2025, alle 10:30 (PST). La presentazione sarà trasmessa in diretta e sarà accessibile attraverso Investor.Incyte.com. Una registrazione della trasmissione sarà disponibile per 30 giorni.
Incyte (Nasdaq: INCY) anunció su participación en la 43ª Conferencia Anual de Atención Médica de J.P. Morgan.
El evento se llevará a cabo el lunes 13 de enero de 2025, a las 10:30 am (PST). La presentación será transmitida en vivo y estará accesible a través de Investor.Incyte.com. Una grabación de la transmisión estará disponible durante 30 días.
Incyte (Nasdaq: INCY)는 제43회 JP 모건 헬스케어 컨퍼런스에 참석한다고 발표했습니다.
이 이벤트는 2025년 1월 13일 월요일 오전 10시 30분(PST)에 열립니다. 발표는 라이브 스트리밍 되며 Investor.Incyte.com을 통해 접근할 수 있습니다. 스트리밍 재생은 30일 동안 제공됩니다.
Incyte (Nasdaq: INCY) a annoncé sa participation à la 43ème Conférence Annuelle J.P. Morgan sur la Santé.
L'événement se déroulera le lundi 13 janvier 2025, à 10h30 (PST). La présentation sera diffusée en direct et sera accessible via Investor.Incyte.com. Un replay de la diffusion sera disponible pendant 30 jours.
Incyte (Nasdaq: INCY) gab seine Teilnahme an der 43. jährlichen J.P. Morgan Healthcare-Konferenz bekannt.
Die Veranstaltung findet am Montag, den 13. Januar 2025, um 10:30 Uhr (PST) statt. Die Präsentation wird live im Internet übertragen und ist über Investor.Incyte.com zugänglich. Eine Wiederholung der Übertragung ist für 30 Tage verfügbar.
- None.
- None.
The presentation will be webcast live and can be accessed at Investor.Incyte.com and will be available for replay for 30 days.
About Incyte
A global biopharmaceutical company on a mission to Solve On., Incyte follows the science to find solutions for patients with unmet medical needs. Through the discovery, development and commercialization of proprietary therapeutics, Incyte has established a portfolio of first-in-class medicines for patients and a strong pipeline of products in Oncology and Inflammation & Autoimmunity. Headquartered in
For additional information on Incyte, please visit Incyte.com or follow us on social media: LinkedIn, X, Instagram, Facebook, YouTube.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241217310994/en/
Incyte
Media
media@incyte.com
Investors
ir@incyte.com
Source: Incyte
FAQ
When is Incyte presenting at the J.P. Morgan Healthcare Conference?
Where can I watch the Incyte presentation at the J.P. Morgan Healthcare Conference?
For how long will the Incyte presentation replay be available?
What time is the Incyte presentation at the J.P. Morgan Healthcare Conference?
How can I access the Incyte webcast of the J.P. Morgan Healthcare Conference?
